Items by Bailey, Sarah

Book Sections

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

Articles

Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.

Drew, C. J. G., O'Reilly, K. C., Lane, M. A. and Bailey, S. J., 2011. Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience, 172, pp. 66-73.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl, naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

Trent, S., Drew, C. J. G., Mitchell, P. J. and Bailey, S. J., 2009. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. European Neuropsychopharmacology, 19 (12), pp. 876-886.

O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.

O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.

O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.

O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.

Bailey, S. J., Ravier, M. A. and Rutter, G. A., 2007. Glucose-dependent regulation of γ-Aminobutyric Acid (GABAA) receptor expression in mouse pancreatic islet α-cells. Diabetes, 56 (2), pp. 320-327.

Mountjoy, P. D., Bailey, S. J. and Rutter, G. A., 2007. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia, 50, pp. 168-177.

O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.

Slater, C. R., Fawcett, P. R. W., Walls, T. J., Lyons, P. R., Bailey, S. J., Beeson, D., Young, C. and Gardner-Medwin, D., 2006. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain, 129, pp. 2061-2076.

Woodhall, G. L., Bailey, S. J., Thompson, S. E., Evans, D. I. P. and Jones, R. S. G., 2005. Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus, 15 (2), pp. 232-245.

Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.

Bailey, S. J., Dhillon, A., Woodhall, G. L. and Jones, R. S. G., 2004. Lamina-specific differences in GABAB autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology, 46, pp. 31-42.

Bailey, S. J. and Toth, M., 2004. Variability in the benzodiazepine response of serotonin 5-HT 1A receptor null mice displaying anxiety-lie phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA A receptors. Journal of Neuroscience, 24 (28), pp. 6343-6351.

Bailey, S. J., Stocksley, M. A., Buckel, A., Young, C. and Slater, C. R., 2003. Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats. Journal of Neuroscience, 23 (6), pp. 2102-2111.

Wood, S. J. and Toth, M., 2001. Molecular pathways of anxiety revealed by knockout mice. Molecular Neurobiology, 23 (2-3), pp. 101-119.

Wood, S. and Slater, C. R., 2001. Safety factor at the neuromuscular junction. Progress in Neurobiology, 64 (4), pp. 393-429.

Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.